1. Home
  2. WKEY vs ONCY Comparison

WKEY vs ONCY Comparison

Compare WKEY & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WISeKey International Holding Ltd

WKEY

WISeKey International Holding Ltd

HOLD

Current Price

$8.56

Market Cap

98.4M

Sector

Technology

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$1.24

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKEY
ONCY
Founded
1999
1998
Country
Switzerland
Canada
Employees
N/A
N/A
Industry
EDP Services
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.4M
94.0M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
WKEY
ONCY
Price
$8.56
$1.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$10.50
$6.00
AVG Volume (30 Days)
194.2K
1.0M
Earning Date
09-23-2025
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,994,000.00
N/A
Revenue This Year
$32.29
N/A
Revenue Next Year
$89.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.33
52 Week High
$19.80
$1.51

Technical Indicators

Market Signals
Indicator
WKEY
ONCY
Relative Strength Index (RSI) 49.72 66.44
Support Level $8.10 $0.98
Resistance Level $9.37 $1.30
Average True Range (ATR) 0.69 0.08
MACD 0.03 0.03
Stochastic Oscillator 37.13 84.21

Price Performance

Historical Comparison
WKEY
ONCY

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: